Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Cohort Study Evaluating the Use and Efficacy of Pomalidomide in Patients With Multiple Myeloma in Routine Clinical Practice

NCT02902900 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02902900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Cohort Study Evaluating the Use and Efficacy of Pomalidomide in Patients With Multiple Myeloma in Routine Clinical Practice
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
April 1, 2015
Completion date
May 31, 2022
Enrollment
2,504 (actual)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma